Cutler Group LP Novo Cure LTD Call Options Transaction History

Cutler Group LP

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	SELL	$12.42 - $17.29 $27,324 - $38,038	-2,200 Reduced 91.67%	200 $0
Q4 2023 Jan 18, 2024	BUY	$11.13 - $15.78 $1,113 - $1,578	100 Added 4.35%	2,400 $0
Q3 2023 Nov 07, 2023	SELL	$16.15 - $42.35 $58,139 - $152,460	-3,600 Reduced 61.02%	2,300 $0
Q2 2023 Jul 18, 2023	SELL	$40.29 - $82.51 $366,639 - $750,841	-9,100 Reduced 60.67%	5,900 $2,000
Q1 2023 May 01, 2023	BUY	$56.44 - $118.81 $507,960 - $1.07 Million	9,000 Added 150.0%	15,000 $18,000
Q4 2022 Feb 07, 2023	BUY	$63.98 - $85.37 $70,378 - $93,907	1,100 Added 22.45%	6,000 $100,000
Q3 2022 Oct 25, 2022	BUY	$67.99 - $89.57 $67,990 - $89,570	1,000 Added 25.64%	4,900 $63,000
Q2 2022 Aug 04, 2022	SELL	$56.6 - $89.9 $515,060 - $818,090	-9,100 Reduced 70.0%	3,900 $43,000
Q1 2022 Apr 14, 2022	BUY	$60.15 - $84.52 $781,950 - $1.1 Million	13,000 New	13,000 $96,000
Q1 2021 Apr 26, 2021	SELL	$124.11 - $190.17 $111,699 - $171,153	-900 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$57.05 - $95.75 $51,345 - $86,175	900 New	900 $9,000
Q4 2019 Feb 06, 2020	SELL	$68.3 - $93.8 $409,800 - $562,800	-6,000 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$42.22 - $63.23 $253,320 - $379,380	6,000 New	6,000 $37,000
Q1 2018 May 11, 2018	SELL	$19.3 - $23.65 $189,140 - $231,770	-9,800 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$16.3 - $21.9 $47,270 - $63,509	-2,900 Reduced 22.83%	9,800 $5,000
Q3 2017 Oct 17, 2017	BUY	$18.05 - $21.75 $229,235 - $276,225	12,700	12,700 $27,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.